InnoCare Pharma Limited (9969.HK) HKSE

13.00

-0.07(-0.54%)

Updated at January 15 10:27AM

Currency In HKD

Valuation

Market Cap9.72B
Enterprise Value4.77B
P/E Ratio-88.59
PEG Ratio12.4
Price/Sales Ratio11.95
Price/Book Ratio2.83
Enterprise/Revenue8.1
Enterprise/EBITDA-55.59

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-0.16
Operating Margin0.11

Management Effectiveness

Return On Assets-0.02
Return On Equity-0.03

Income Statement

Revenue1.01B
Revenue/Share0.83
Gross Profit871.01M
EBITDA-463.49M
Net Income-440.63M
Diluted EPS-0.26

Balance Sheet

Total Cash7.67B
Total Cash/Share4.35
Total Debt1.82B
Total Debt/Equity0.25
Current Ratio6.54
Book Value Per Share4.14

Price History

52-Week Change143.84
52-Week High20.62
52-Week Low5.13
Moving Average 50 Days13.87
Moving Average 200 Days14.13

Statistics

Average Volume7.17M
Shares Outstanding1.49B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-0.11
Last Split FactorN/A
Last Split DateN/A